[The role of bisphosphonate in the treatment of bone metastases from prostate cancer].
BACKGROUND
Bone metastasis is very frequent in prostate cancer. It is a turning point that marks the severity of the disease. Before metastasis become symptomatic, treatment preventing bone events should be indicated.


OBJECTIVE
To evaluate the role of bisphosphonate in the treatment of bone metastases from prostate cancer.


METHODS
A review of literature.


RESULTS
Bisphosphonates play a very important role to prevent bone mass loss and to reduce bone complication events.


CONCLUSIONS
Bisphosphonates are recommended as preventive treatment at the time of diagnosis of bone metastatic prostate cancer.
Faculte de Medecine de Tunis, Universite Tunis, El Manar, Tunisie.
Sataa
S
Sallami
Samir
S
Ben Rhouma
Karim
K
Cherif
Nawfel
N
Benrais
Ali
A
Horchani
D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology*; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid